Ascentage Pharma Group International (ASPHF) Financials

ASPHF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 477.0 million 393.7 million
Dec. 31, 2025 566.8 million 376.0 million
June 30, 2025 425.2 million 330.8 million
Dec. 31, 2024 358.6 million 321.1 million

ASPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -89.9 million ?
Dec. 31, 2025 -112.8 million ?
June 30, 2025 -63.1 million 1.8 million
Dec. 31, 2024 32.2 million 1.7 million

ASPHF Net Income

No data available :(

ASPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 279.0 million 89.1 million 2.1 million
Dec. 31, 2025 353.2 million 106.2 million 3.2 million
June 30, 2025 231.9 million 121.0 million 3.7 million
Dec. 31, 2024 169.4 million 119.0 million 4.1 million

ASPHF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 54.9 million
Dec. 31, 2025 52.9 million
June 30, 2025 47.7 million
Dec. 31, 2024 40.6 million

ASPHF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.7 million 99.6 million 46.4 million -
Dec. 31, 2025 1.1 million 84.1 million 45.7 million -
June 30, 2025 2.8 million 73.8 million 33.1 million 19.2 million
Dec. 31, 2024 1.1 million 68.9 million 28.3 million 14.6 million

ASPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 43.9 million 7.0 million
Dec. 31, 2025 47.8 million 9.8 million
June 30, 2025 4.5 million 3.0 million
Dec. 31, 2024 21.5 million 1.9 million

ASPHF

Price: $3.75

52 week price:
3.75
9.32

Earnings Per Share: -0.59 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.5 billion

Links: